EXAS Live signals | Maximize Profits with Getagraph.com

SELL 1063 min ago

@ $60.87

Issued: 19 Apr 2024 @ 15:24

Return: 0.14%

Previous signal: Apr 19 - 09:30

Previous signal: Buy

Return: -3.13 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	2.09M
Average Volume	2.42M
Market Cap	11.07B
EPS	$0 ( 2024-02-21 )
Next earnings date	( $-0.500 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-53.95
ATR14	$3.11 (5.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Condella Sarah	Sell	2 000	Common Stock
2024-04-02	Baranick Brian	Sell	924	Common Stock
2024-03-28	Condella Sarah	Sell	2 000	Common Stock
2024-02-29	Orville Jacob A	Buy	4 724	Common Stock
2024-03-01	Orville Jacob A	Sell	2 154	Common Stock

INSIDER POWER
36.33
Last 100 transactions
Buy: 542 709 \| Sell: 252 987

Volume Correlation

Long: 0.64 (weak)

Short: 0.47 (neutral)

Signal:(45) Neutral

Exact Sciences Corp Correlation

10 Most Positive Correlations
AVEO	0.942
ITMR	0.941
HZNP	0.928
LUNA	0.926
WLFC	0.925
MLCO	0.923
FCBP	0.922
NWLI	0.92
OBAS	0.916
NWFL	0.914

10 Most Negative Correlations
GOSS	-0.97
VS	-0.951
XFOR	-0.95
GROM	-0.938
TOPS	-0.933
USEG	-0.932
QTEK	-0.931
TRVN	-0.931
SG	-0.93
THTX	-0.929

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Exact Sciences Corp Correlation - Currency/Commodity

0.22
( neutral )

0.06
( neutral )

0.00
( neutral )

-0.80
( moderate negative )

-0.75
( moderate negative )

0.15
( neutral )

Exact Sciences Corp Financials

Annual	2023
Revenue:	$2.50B
Gross Profit:	$1.85B (73.83 %)
EPS:	$-1.130

Q4	2023
Revenue:	$646.89M
Gross Profit:	$475.07M (73.44 %)
EPS:	$-0.270

Q3	2023
Revenue:	$646.89M
Gross Profit:	$475.07M (73.44 %)
EPS:	$-0.270

Q3	2023
Revenue:	$628.34M
Gross Profit:	$459.81M (73.18 %)
EPS:	$0.00440

Financial Reports:

No articles found.

Exact Sciences Corp

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.